Press Room

Webinar: Evaluating the Best Formulations for Amorphous Solid Dispersions by Spray Drying

Start
Tuesday, February 28, 2023 - 16:00
End
Tuesday, February 28, 2023 - 17:28
Location: online
Webinar session 1 Spray Drying_Feb28 - SEM image of a particle in a dark green background

This is the first session of a three-part webinar series on Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management.

 

Watch On-demand.

Gated content. Registration is required.

 

 

Learn more about this webinar series here.

 

Featured Hovione experts in this webinar
Webinar Series Spray Drying Speakers - Alexandre Ribeiro | Hovione
Webinar Series Spray Drying Speakers - Ines Ramos | Hovione
Webinar Series Spray Drying Speakers - Pedro Monteiro | Hovione
Alexandre Ribeiro, Ph.D.
Senior Analytical Scientist 
R&D, Analytical Development
Inês Ramos, Ph.D.
Scientist 
R&D Oral Drug Product - Formulation Group
Pedro Monteiro, M.Sc. 
Scientist 
R&D Oral Drug Product - Formulation Group​​​​

 

Alexandre Ribeiro, Inês Ramos, and Pedro Monteiro kick-off the series by focusing on the role of amorphous solid dispersions in modern oral drugs and how the right formulation for a drug candidate can be selected using Hovione’s proprietary screening methodology. This method is performed via an automated high-throughput system that was developed over many years of experience with formulation of ASDs. The speakers will provide an understanding of the methodology, the evaluation process, and the studies typically utilized, as well as key information needed to make a formal assessment of the best candidates.

 

Your Key Learning Objectives

  • Understand the increasing importance of amorphous solid dispersions in oral drug delivery of new chemical entities
  • Get an overview of Hovione’s methodology to screen the best formulations in amorphous solid dispersions for a given API candidate
  • Learn about the formulation criteria based on stability, performance, and manufacturability data

 

Who Should Attend 
This webinar is suitable for anyone working in formulation of oral drugs, procurement, and outsourcing teams or as a project manager, who is interested in understanding the whole assessment process and their role in it.

 

 

 

Watch On-demand.

Gated content. Registration is required.

 

 

Do you have a challenging project needing differentiating technologies and an innovative approach?

Get in touch today

 

 

 

Also in the Press Room

See All

Hovione’s Eunice Costa Shares Insights on Inhaled Medicine Formulation in Pharmaceutical Technology eBook The demand for efficient inhalation therapies is higher than ever. At Hovione we are focusing on particle size, dispersion performance, and formulation integrity to ensure optimal bioavailability and patient outcomes.  To learn more about or work, do not miss the contribution of Eunice Costa, our R&D Director for Inhalation & Advanced Drug Delivery, in the latest Pharmaceutical Technology eBook – “Trends in Formulation”.  In her interview, Eunice discusses key challenges and considerations in formulating inhaled medicines, emphasizing the importance of excipient selection, device compatibility, and patient-centric design for successful drug delivery to the lungs. With respiratory diseases at the forefront, especially following the COVID-19 pandemic, the demand for efficient inhalation therapies is higher than ever. Eunice sheds light on how Hovione is tackling these demands by focusing on particle size, dispersion performance, and formulation integrity to ensure optimal bioavailability and patient outcomes. Explore Eunice Costa’s full insights on this crucial area of drug development in Pharmaceutical Technology's September 2024 eBook. This resource provides an in-depth look into the complexities of inhaled drug formulations and the exciting innovations shaping the future of respiratory treatments.   Read the full article at Pharmaceutical Technology eBook Read the Trends in Formulation eBook at PharmTech  

Article

Formulating Inhaled Medicines

Sep 24, 2024

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024